In this study, to elucidate the changes in plasma ATN in clinically diagnosed AD patients, the ultrasensitive Simoa detection method was used to measure the expression levels of plasma Aβ42, Aβ40, t-tau, p-tau181, and NfL in patients with mild-to-moderate AD. The gene discussed is NEFL; the disease is Alzheimer disease.